U.S. Department of Health and Human Services, Food and Drug Administration
Food and Drug Administration Research
Key facts
- Open now
- 9 grants
- Opening soon
- 44 grants
- Type of help
- Cooperative agreement (a grant with close agency involvement), project grant
- Typical award
- Varies by grant mechanism and program specific requirements.
- Deadlines
- Applicants should review the individual Funding Opportunity Announcement (FOA) issued under this CFDA program to see the application deadline information.
Open now
- Minor Use Minor Species Development of Drugs (R01) · Due Jan 29, 2027 · 114 days left
- Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed · Due Apr 1, 2027 · 176 days left
- NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens · Due Apr 1, 2027 · 176 days left
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) · Due Apr 5, 2027 · 180 days left
- Laboratory Flexible Funding Model (LFFM) · Due Jan 11, 2028 · 461 days left
- Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional) · Due Feb 8, 2028 · 489 days left
- Animal and Veterinary Innovation Centers (U18) · Due May 12, 2028 · 583 days left
- Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required) · Due May 16, 2028 · 587 days left
- Vet-LIRN Capacity-Building Project and Equipment Grants (U18) · Due Sep 4, 2028 · 698 days left
Opening soon
Announced, but you can't apply yet. Get ready now.
- Rapid Response Team (RRT) Cooperative Agreement · The funder's estimated date (Dec 1, 2022) has passed. Check the official notice Estimate, not confirmed by the funder
- FDA OMHHE Convener for Racial & Ethnic minority Acceleration Consortium for Health Equity (REACH) · The funder's estimated date (Mar 3, 2023) has passed. Check the official notice Estimate, not confirmed by the funder
- FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed) · The funder's estimated date (Apr 12, 2023) has passed. Check the official notice Estimate, not confirmed by the funder
- Data Standards for Tobacco Research and Scientific Review Phase 2 · The funder's estimated date (Dec 1, 2023) has passed. Check the official notice Estimate, not confirmed by the funder
- Studies Addressing Rare Neurodegenerative Diseases including ALS · Opening date not announced
- FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed · Opening date not announced
- Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed · Opening date not announced
- Animal Food Regulatory Program Alliance · Opening date not announced
- Retail Food Safety Regulatory Association Collaboration · Opening date not announced
- Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics · Opening date not announced
- Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed · Opening date not announced
- Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives · Opening date not announced
- NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens · Opening date not announced
- Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required · Opening date not announced
- Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed · Opening date not announced
- OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed · Opening date not announced
- African Medical Devices Regulatory Harmonization Program · Opening date not announced
- Integrated Food Safety System Regulatory and Laboratory Training System National Coordination Center · Opening date not announced
- Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional · Opening date not announced
- Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed · Opening date not announced
- Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed · Opening date not announced
- Collaborations to Enhance Drug Development and Regulatory Science · Opening date not announced
- Novel approaches to support therapeutic development in ultra-rare cancers · Opening date not announced
- Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required) · Opening date not announced
- Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities · Opening date not announced
- Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional) · Opening date not announced
- Center for Research on Complex Generics (U18) Clinical Trials Optional · Opening date not announced
- Minor Use Minor Species Development of Drugs (R01) · Opening date not announced
- Critical Path Public Private Partnerships Clinical Trials Optional · Opening date not announced
- REACHing Communities (REACH) Consortium (U01) Clinical Trials Optional · Opening date not announced
- Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required) · Opening date not announced
- Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) Clinical Trial Not Allowed · Opening date not announced
- Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed · Opening date not announced
- Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed · Opening date not announced
- Retail Food Safety Regulatory Association Collaboration CAP · Opening date not announced
- Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed · Opening date not announced
- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required) · Opening date not announced
- Cooperative Agreement to Support Effective Dissemination of Clinical Practice Guidelines · Opening date not announced
- Federal and State Integration Activities to Advance Cooperation and Regulatory Standards Among Animal Food Safety Regulatory Programs · Opening date not announced
- Conformance with the Egg Regulatory Program Standards · Opening date not announced
- Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01) · Opening date not announced
- Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional · Opening date not announced
- Flexible Funding Model-Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U2F) Clinical Trials Not Allowed · Opening date not announced
- Manufactured Foods Flexible Funding Model (MF-FFM) · Opening date not announced
What it pays for
To assist institutions and organizations, to establish, expand, and improve research, demonstration, education and information dissemination activities; acquired immunodeficiency syndrome (AIDS), biologics, blood and blood products, therapeutics, vaccines and allergenic projects; drug hazards, human and veterinary drugs, clinical trials on drugs and devices for orphan products development; nutrition, sanitation and microbiological hazards; medical devices and diagnostic products, radiation emitting devices and materials; food safety and food additives. These programs are supported directly or indirectly by the following Centers and Offices: Center for Biologics Evaluation and Research (CBER); Center for Drug Evaluation and Research (CDER); Center for Devices and Radiological Health (CDRH); Center for Veterinary Medicine (CVM), Center for Food Safety and Applied Nutrition (CFSAN), National Center for Toxicological Research (NCTR), the Office of Orphan Products Development (OPD), the Center for Tobacco Products (CTP), and Office of Regulatory Affairs (ORA), and the Office of the Commissioner (OC). Small Business Innovation Research (SBIR) Programs: to stimulate technological innovation; to encourage the role of small business to meet Federal research and development needs; to increase private sector commercialization of innovations derived from Federal research and development; and to foster and encourage participation by minority and disadvantaged persons in technological innovation. Funding support for scientific conferences that are relevant to the FDA scientific...
Who can apply
Applicants should review the individual funding opportunity announcement issued under this CFDA program to see which applicant organizations are eligible to apply.
How applications are judged
Applicants should review the individual Funding Opportunity Announcement (FOA) issued under this CFDA program to see the specific evaluation criteria that applies.
Match
None required (federal program listing).
Who in Tennessee has won this program
20 awards to Tennessee groups since 2016 · 0 in Rhea County. Largest shown:
| Past winner | Where | Amount | Fiscal year |
|---|---|---|---|
| University of Tennessee | Knoxville, Knox County | $6.5M | 2020 |
| State of Tennessee | Nashville | $2.7M spent that year | 2025 |
| Vanderbilt University Medical Center | Nashville, Davidson County | $2.5M | 2019 |
| Tennessee Department of Agriculture | Nashville, Davidson County | $2.4M | 2020 |
| University of Tennessee | Memphis, Shelby County | $2M | 2017 |
| Tennessee Department of Agriculture | Nashville, Davidson County | $1.9M | 2020 |
| University of Tennessee | Knoxville, Knox County | $1.8M | 2025 |
| Franklin Special School District | Franklin, Williamson County | $1.8M | 2025 |
| Vanderbilt University Medical Center | Nashville, Davidson County | $1.6M | 2022 |
| Tennessee Department of Agriculture | Nashville, Davidson County | $1.3M | 2021 |
| Tennessee Department of Health | Nashville, Davidson County | $1.3M | 2020 |
| Tennessee Department of Agriculture | Nashville, Davidson County | $1.3M | 2016 |
Source: USAspending.gov, Federal Audit Clearinghouse.
Tennessee groups that got this money through a state agency or another organization
This federal money also reaches local groups as pass-through grants. 22 pass-through grants on file · 0 in Rhea County. Largest shown:
| Past winner | Where | Through | Amount | Fiscal year |
|---|---|---|---|---|
| Combinedbrain, Inc | Brentwood | Duke University | $538K | 2025 |
| Vanderbilt University Medical Center | Nashville, Davidson County | Harvard Pilgrim Health Care | $241K spent that year | 2025 |
| Vanderbilt University Medical Center | Nashville, Davidson County | Regents of the University of California, San Francisco, the | $75K | 2023 |
| Vanderbilt University Medical Center | Nashville, Davidson County | Regents of the University of California, San Francisco, the | $69K | 2025 |
| Vanderbilt University Medical Center | Nashville, Davidson County | Mayo Clinic Hospital | $51K spent that year | 2025 |
| Volumetrix Inc. | Nashville, Davidson County | The Children's Hospital of Philadelphia | $50K | 2023 |
| Vanderbilt University Medical Center | Nashville, Davidson County | Mayo Clinic | $43K | 2023 |
| Vanderbilt University Medical Center | Nashville, Davidson County | Mayo Clinic | $43K | 2024 |
| Vanderbilt University Medical Center | Nashville, Davidson County | Cumberland Pharmaceuticals Inc | $42K spent that year | 2025 |
| Loch & Key Productions, LLC | Knoxville, Knox County | Association of Public Health Laboratories, Inc. (THE) | $33K | 2025 |
| Vanderbilt University Medical Center | Nashville, Davidson County | The Queen's Medical Center | $32K | 2024 |
| Vanderbilt University Medical Center | Nashville, Davidson County | University of California-San Francisco | $29K spent that year | 2025 |
Source: USAspending.gov pass-through reports (the first recipient reports each one of $30,000 or more).